Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...

Animal tests show promise to target invasive strain of E. coli but approval for use in humans is still years away ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) Q3 2025 Earnings Call Transcript November 12, 2025 Acurx Pharmaceuticals, Inc.

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, ...

Half of the Staphylococcus epidermidis isolates found in raw milk from dairy cattle and sheep were multidrug resistant.

Scientists have discovered a never-before-seen antibiotic that shows promising in treating drug-resistant infections.

Keeping your gut healthy doesn't always have to involve supplements. Foods rich in prebiotics have been proven to provide ...

Among more than 140,000 visits for ear infection, only 15% used watchful waiting, but treatment failure rates were low and ...

The sweet-and-savory spice that can slash harmful inflammation - and stop caffeine cravings - Spice has the ability to reduce ...

Napoleonville, Louisiana - Newsfile Corp. - November 7, 2025 - Impact Fusion (OTCID: IFUS). The Florida Statewide Organization of Omega Psi Phi Fraternity, Inc., the ...

From cancer-resistant mole rats to 200-year-old whales, evolution has equipped long-lived species with unique biological ...

Aging brings about a range of changes—often unwelcome—to our bodies: sagging skin, graying or thinning hair, and a decline in muscle strength and ...